Candida auris has unprecedently emerged as a multidrug resistant fungal pathogen,
considered a serious global threat due to its potential to cause nosocomial outbreaks and …

Candida auris recently emerged as an urgent public health threat, causing outbreaks of
invasive infections in healthcare settings throughout the world. This fungal pathogen persists …

Candida auris is an emerging fungal pathogen with unusual evolutionary history—there are
multiple distinct phylogeographic clades showing a near simultaneous transition from a …

Candida auris is an emerging multidrug-resistant fungal pathogen responsible for
nosocomial outbreaks of invasive candidiasis. Although several studies on the pathogenicity …

Galleria mellonella larvae have become a widely accepted and utilised infection model due
to the functional homology displayed between their immune response to infection and that …

Abstract The World Health Organization (WHO) in 2022 developed a fungal priority
pathogen list. Candida auris was ultimately ranked as a critical priority pathogen. PubMed …

Candida auris is an emergent multidrug-resistant fungal pathogen considered a severe
global threat due to its capacity to cause nosocomial outbreaks and deep-seated infections …

Candida auris is a multiresistant pathogenic yeast commonly isolated from bloodstream
infections in immunocompromised patients. In this work, we infected Galleria mellonella …

Candidiasis is an opportunistic infection affecting immunosuppressed and hospitalized
patients, with mortality rates approaching 40% in Colombia. The growing pharmacological …

Candida auris, first described in 2009, is an opportunistic pathogenic yeast that causes
nosocomial outbreaks around the world, with high mortality rates associated with therapeutic …